Fortrea appoints Jason Knoblauch as chief financial officer

• Fortrea (NASDAQ:FTRE) appointed Jason Knoblauch as Chief Financial Officer, effective July 6, 2026.
• He succeeds Jill McConnell, who will support a smooth transition.
• The company reaffirmed its full-year 2026 guidance for revenue of $2,550–$2,650 million and adjusted EBITDA of $190–$220 million.

Fortrea (NASDAQ:FTRE) appointed Jason Knoblauch as Chief Financial Officer, effective July 6, 2026.

Knoblauch succeeds Jill McConnell, who will support a smooth transition.

Fortrea also reaffirmed its full-year 2026 financial guidance, targeting revenue between $2,550 million and $2,650 million with adjusted EBITDA of $190 million to $220 million.

The appointment strengthens the company’s financial leadership as it continues to execute on its strategic priorities in the contract research organization sector.

Fortrea is a global contract research organization providing clinical development and patient access solutions to biopharmaceutical and medical device companies worldwide.

The company remains focused on delivering operational excellence and supporting its clients’ drug development programs across multiple therapeutic areas.